← Back to all trials
Recruiting
NCT07768007
Real-time Opioid Study
Conditions: Substance Use Disorder (SUD)
Sex: All
Ages: 18 Years – 50 Years
Healthy volunteers: No
Phase: NA
Enrollment: 3
Sponsor: Yale University
Location: APT Foundation New Haven Connecticut
Summary
This feasibility study collects initial data on the use of an fMRI neurofeedback protocol for treating anhedonia in methadone-treated individuals with opioid use disorder (OUD). The intervention tested has previously been shown to reduce anhedonia in individuals with depression and this study is collecting first-in-human data in an OUD population. Investigators will assess tolerability of the intervention and collect preliminary data from 2-3 subjects monitoring changes in anhedonia, non-substance-related autobiographical memory recall, and meaning in life.
Eligibility Criteria
Inclusion Criteria:
* ≥3 months of methadone treatment for OUD
* Presence of anhedonia, as assessed via SHAPS
* Room for improvement in specific autobiographical memory recall, as assessed via AMT
Exclusion Criteria:
* Failure to pass an MRI screening
* Women who are pregnant
* Psychosis, as assessed via Yale PRIME Early Psychosis Screening Test
* Serious suicidal ideation
* Serious medical condition
* Legally blind
Source: ClinicalTrials.gov (NCT07768007). StuddyBuddy aggregates publicly available trial information.